Roble, Belko & Company, Inc Pfizer Inc Transaction History

Roble, Belko & Company, Inc

$629 Million
Q4 2024

A detailed history of Roble, Belko & Company, Inc transactions in Pfizer Inc stock. As of the latest transaction made, Roble, Belko & Company, Inc holds 5,801 shares of PFE stock, worth $150,071. This represents 0.02% of its overall portfolio holdings.

Number of Shares

5,801

Previous 3,875 49.7%

Holding current value

$150,071

Previous $112,000 37.5%

% of portfolio

0.02%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 14, 2025	BUY	$24.8 - $30.19 $47,764 - $58,145	1,926 Added 49.7%	5,801 $154,000
Q2 2024 Aug 07, 2024	SELL	$25.26 - $29.6 $13,514 - $15,836	-535 Reduced 12.13%	3,875 $108,000
Q1 2024 Apr 11, 2024	SELL	$25.89 - $29.73 $3,676 - $4,221	-142 Reduced 3.12%	4,410 $122,000
Q4 2023 Feb 01, 2024	SELL	$26.13 - $33.94 $18,291 - $23,758	-700 Reduced 13.33%	4,552 $131,000
Q3 2023 Nov 01, 2023	SELL	$32.09 - $37.51 $18,515 - $21,643	-577 Reduced 9.9%	5,252 $174,000
Q2 2023 Aug 04, 2023	SELL	$36.12 - $41.79 $216,467 - $250,447	-5,993 Reduced 50.69%	5,829 $214,000
Q1 2023 May 10, 2023	SELL	$39.39 - $51.28 $236,812 - $308,295	-6,012 Reduced 33.71%	11,822 $482,000
Q4 2022 Feb 08, 2023	BUY	$41.75 - $54.5 $17,159 - $22,399	411 Added 2.36%	17,834 $914,000
Q2 2022 Aug 10, 2022	SELL	$46.53 - $55.17 $6,188 - $7,337	-133 Reduced 0.76%	17,423 $913,000
Q1 2022 May 06, 2022	BUY	$45.75 - $56.69 $6,450 - $7,993	141 Added 0.81%	17,556 $909,000
Q4 2021 Feb 07, 2022	SELL	$41.32 - $61.25 $81,152 - $120,295	-1,964 Reduced 10.13%	17,415 $1.03 Million
Q3 2021 Nov 03, 2021	BUY	$39.25 - $50.42 $19,821 - $25,462	505 Added 2.68%	19,379 $833,000
Q1 2021 May 12, 2021	BUY	$33.49 - $37.77 $107,168 - $120,864	3,200 Added 20.42%	18,874 $684,000
Q3 2020 Nov 10, 2020	SELL	$31.75 - $37.25 $1.25 Million - $1.46 Million	-39,295 Reduced 71.49%	15,674 $575,000
Q2 2020 Aug 10, 2020	SELL	$30.12 - $36.54 $93,522 - $113,456	-3,105 Reduced 5.35%	54,969 $1.8 Million
Q1 2020 May 05, 2020	BUY	$27.03 - $38.62 $863,067 - $1.23 Million	31,930 Added 122.13%	58,074 $1.9 Million
Q3 2019 Nov 13, 2019	BUY	$32.49 - $42.13 $185,745 - $240,857	5,717 Added 27.99%	26,144 $939,000
Q2 2019 Aug 13, 2019	BUY	$36.98 - $41.52 $138,711 - $155,741	3,751 Added 22.49%	20,427 $885,000
Q1 2019 May 10, 2019	BUY	$37.5 - $41.2 $12,975 - $14,255	346 Added 2.12%	16,676 $708,000
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $616,327 - $702,681	16,021 Added 5184.79%	16,330 $713,000
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $63,086 - $73,188	-1,977 Reduced 86.48%	309 $11,000
Q3 2017 Nov 08, 2017	BUY	$31.0 - $34.15 $70,866 - $78,066	2,286	2,286 $82,000

Others Institutions Holding PFE

# of Institutions

3,228

Shares Held

3.62B

Call Options Held

77.1M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roble, Belko & Company, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Roble, Belko & Company, Inc with notifications on news.

Account

Roble, Belko & Company, Inc Pfizer Inc Transaction History